Fund portfolios with allocations to the U.S. producer of next-generation artificial intelligence chips were at their concentration limits before the stock on Monday gave up some more of its spectacular recent gains.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
